相关实验视频

Updated: May 12, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

对剂量密集治疗癌症患者的长期心脏毒性进行可行性研究

Markus B Heckmann^1,2,3, Julia Lehmann⁴, Daniel Finke^1,2

¹Department for Cardiology, Angiology, and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.

International journal of heart failure

|June 16, 2025

概括

乳腺癌的高剂量化疗显示了与传统方法相比的长期心脏安全性. 这种方法可以保护心脏功能,心力衰竭的发病率很低.

科学领域:

心脏病学心脏病学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

剂量密集的以环素为基础的化疗是高风险乳腺癌的关键策略.
加快的环素治疗方案的长期心脏毒性需要进一步调查.
评估心脏安全对于优化乳腺癌治疗方案至关重要.

研究的目的:

评估高剂量环素化疗与传统方案的长期心脏安全性.
为了比较治疗组之间的左心室喷射分数 (LVEF) 和全球纵向应变 (GLS).
为了确定乳腺癌患者化疗后心脏功能障碍的预测因素.

主要方法:

对101名非转移性乳腺癌患者 (2007-2014) 的回顾性研究.
分类为剂量密集 (n=44) 和常规 (n=57) 化疗组.
长期随访 (7-10年) 包括心声回声 (LVEF,GLS),心电图和心脏生物标志物.

主要成果:

两组都保持了左心室缩功能 (LVEF和GLS).
在剂量密集组的28.6%和常规组的47.4%观察到透缩功能障碍.
年龄和高血压是扩张性功能障碍的显著预测因素;反环素诱导的心力衰竭是罕见的.

结论:

剂量密集的环素治疗表现出与传统疗法相比的长期心脏安全性.
保持缩功能和低心力衰竭发病率支持剂量密集的治疗方案.
在乳腺癌管理中,个性化心脏风险评估和监测至关重要.

关键词:

人类循环类药物.抗瘤药剂是一种抗瘤药剂.乳腺新生体的形成.心脏有毒性 - 心脏有毒性药物药物药物药物药物

更多相关视频

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

相关概念视频

Toxicity Testing in Animals

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...